BioSpace News Archive

pringCM, a DocuSign company, today announced that it has launched a social media campaign to raise money for New Genes, a not-for-profit organization dedicated to gene replacement therapy to address terminal childhood diseases.

Thomas Rapisardo, M.D., today received the first annual Healthcare Hero Award from The Independence Fund for his exemplary service and dedication to America’s wounded, ill, and injured Veterans.

b-ONE Ortho Corp. today announced it has received 510(k) clearance for its first device, the b-ONETM Total Hip System, from the U.S. Food and Drug Administration (FDA).

JOOL Health today announced a new partnership to bring JOOL’s groundbreaking solution to the faculty and staff of the University of Delaware. JOOL is a digital personal life coach that improves overall employee well-being and organizational performance, by combining the science of purpose with advanced data analytics.

Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Fulphila®, a biosimilar to Amgen’s Neulasta® (pegfilgrastim).

Los Altos High School Named Recipient of $20,000 Grant to Bolster Science Program

Colgate-Palmolive has been named to the Dow Jones Sustainability Indices (DJSI) for the second consecutive year in recognition of the company’s demonstrated commitment to sustainability goals and ethical behavior, as well as the value it has generated for shareholders.

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib.

Today, U.S. Surgeon General Jerome M. Adams released the report Facing Addiction in America: The Surgeon General’s Spotlight on Opioids, calling for a cultural shift in the way Americans talk about the opioid crisis, and recommending actions that can prevent and treat opioid misuse and promote recovery.

Leadership Appointment Supports Strategic Shift to Build Oncology Drug Delivery Company